FDA Approvals
Welcome to our special section for new drugs and medical devices on the
Drug and Medical Device Approval page. Here, you find a summary of
drugs and medical devices approved by the Food and Drug Administration
(FDA). For more information, click on links to the FDA Web site.
This page was last updated on April 03, 2006
| Date |
Generic Name |
Trade Name |
Details |
| May 11, 2006 |
varenicline tartrate |
Chantix ® tablets |
 |
| May 3, 2006 |
decitabine |
Dacogen injection |
 |
| March 16, 2006 |
tool for cancer detection |
LUMA Cervical Imaging System |
 |
| March 1, 2006 |
cetuximab |
Erbitux |
 |
| February 28, 2006 |
selegiline |
Emsam |
 |
| February 22, 2006 |
generic version of the brand name drug Flonase |
Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase |
 |
| February 21, 2006 |
anidulafungin |
Eraxis |
 |
| February 3, 2006 |
rotavirus vaccine |
RotaTeq |
 |
| February 3, 2006 |
laboratory test to diagnose strains of influenza |
Influenza A/H5 (Asian lineage) Virus Real-time RT-PCR Primer and Probe Set |
 |
| January 31, 2006 |
lubiprostone |
Amitiza |
 |
| January 31, 2006 |
ranolazine |
Ranexa |
 |
| January 27, 2006 |
insulin human [rDNA origin] inhalation powder |
Exubera |
 |
| January 26, 2006 |
sunitinib |
Sutent |
 |
| January 9, 2006 |
immune globulin subcutaneous (human) |
Vivaglobin |
 |
| November 9, 2005 |
deferasiro |
Exjade |
 |
| November 4, 2005 |
generic version of Epivir oral solution 10 mg/mL |
Lamivudine oral solution 10 mg/mL |
 |
| October 31, 2005 |
nelarabine |
Arranon |
 |
| September 21, 2005 |
silicone gel-filled breast implants |
none available |
 |
| August 31, 2005 |
flu vaccine |
Fluarix |
 |
| August 22, 2005 |
blood test |
Invader UGT1A1 Molecular Assay |
 |
| July 28, 2005 |
silicone gel-filled breast implants |
MemoryGel silicone gel-filled breast implants |
 |
| July 13, 2005 |
zidovudine |
First generic version of the already-approved Retrovir brand |
 |
| July 8, 2005 |
lamivudine and zidovudine |
First generic version of the already-approved Combivir brand |
 |
| June 10, 2005 |
tetanus toxoid (T), reduced diphtheria toxoid (d) and acellular pertussis vaccine (ap), adsorbed |
Adacel |
 |
| May 9, 2005 |
DNA test |
The Tag-It Cystic Fibrosis Kit |
 |
| May 5, 2005 |
ropinirole |
Requip |
 |
| May 3, 2005 |
tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed |
Boostrix |
 |
| April 18, 2005 |
prescription oral rinse |
Oral Rinse |
 |
| April 7, 2005 |
Product to protect against leakage of cerebrospinal fluid after brain surgery |
DuraSeal Dural Sealant System |
 |
| March 30, 2005 |
entecavir |
Baraclude |
 |
| March 23, 2005 |
Endovascular grafting system for treating a certain kind of aneurysm |
GORE TAG Endoprosthesis System |
 |
| March 17, 2005 |
pramlintide acetate |
Symlin |
 |
| March 16, 2005 |
temozolomide |
Temodar |
 |
| February 18, 2005 |
Intravenous drug |
Vaccinia Immune Globulin Intravenous (VIGIV) |
 |
| January 31, 2005 |
Fentanyl transdermal system |
Generic version of Alza Corporation's Duragesic Patch (Fentanyl Transderma). |
 |
| January 25, 2005 |
Lamivudine/zidovudine fixed dose combination tablets and nevirapine tablets |
No trade name given |
 |
| December 23, 2004 |
DNA microarray test |
AmpliChip Cytochrome P450 Genotyping Test |
 |
| December 20, 2004 |
Pegaptanib sodium injection |
Macugen |
 |
| December 16, 2004 |
Trypan blue ophthalmic solution |
Vision Blue |
 |
| December 15, 2004 |
palifermin |
Kepivance |
 |
| November 23, 2004 |
natalizumab |
Tysabri |
 |
| November 19, 2004 |
surgical marker tag |
SurgiChip Tag Surgical Marker system |
 |
| November 19, 2004 |
erlotinib |
Tarceva |
 |
| October 26, 2004 |
Artificial spinal disc |
Charité artificial disc |
 |
| October 22, 2004 |
Device to destroy uterine fibroids |
ExAblate 2000 System |
 |
| October 18, 2004 |
Partial artificial heart |
CardioWest Total Artificial Heart |
 |
| September 24, 2004 |
hydromorphone hydrochloride |
Palladone |
 |
| September 16, 2004 |
Home defibrillator |
HeartStart Home Defibrillator |
 |
| September 13, 2004 |
an intraocular lens |
The Artisan |
 |
| September 7, 2004 |
duloxetine hydrochloride |
Cymbalta |
 |
| August 25, 2004 |
Blood test for newborns |
The NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit |
 |
| August 11, 2004 |
Two drugs including pentetate calcium trisodium injection and pentetate zinc trisodium injection |
Ca-DTPA and Zn-DTPA |
 |
| August 3, 2004 |
injectable filler |
Sculptra |
 |
| August 2, 2004 |
abacavir/lamivudine and tenofovir disoproxil/emtricitabine |
Epzicom and Truvada |
 |
| July 29, 2004 |
acamprosate |
Campral |
 |
| July 20, 2004 |
Botulinum Toxin Type A |
Botox |
 |
| July 15, 2004 |
imiquimod |
Aldara |
 |
| July 12, 2004 |
Imaging tool for detection of lung cancer |
ImageChecker CT CAD software system |
 |
| July 7, 2004 |
Device for heart surgery |
Da Vinci Endoscopic Instrument Control System |
 |
| June 28, 2004 |
Medicinal leeches |
Leeches |
 |
| May 19, 2004 |
azacitidine |
Vidaza |
 |
| May 19, 2004 |
docetaxel |
Taxotere |
 |
| May 6, 2004 |
hyaluronidase for injection |
Vitrase |
 |
| April 21, 2004 |
apomorphine |
Apokyn |
 |
| March 26, 2004 |
A rapid HIV diagnostic test kit |
OraQuick Rapid HIV-1/2 Antibody Test |
 |
| March 23, 2004 |
Oxycodone hydrochloride extended-release products |
Generic versions |
 |
| March 8, 2004 |
cinacalcet |
Sensipar |
 |
| February 26, 2004 |
bevacizumab |
Avastin |
 |
| February 26, 2004 |
A ventricular assist device (heart pump for children) |
DeBakey VAD Child |
 |
| February 12, 2004 |
cetuximab |
Erbitux |
 |
| February 5, 2004 |
pemetrexed disodium |
Alimta |
 |
| December 17, 2003 |
Test kits for genetic clotting risk |
The Factor V Leiden kit and the Factor II (prothrombin) G20210A kit |
 |
| December 12, 2003 |
hyaluronic acid |
Restylane |
 |
| December 9, 2003 |
Test kit for anthrax |
The Redline Alert test |
 |
| November 25, 2003 |
abarelix |
Plenaxis |
 |
| November 21, 2003 |
tadalafil |
Cialis |
 |
| November 14, 2003 |
ethinyl estradiol and norethindrone |
Ovcon 35 |
 |
| October 17, 2003 |
memantine |
Namenda |
 |
| October 10, 2003 |
estradiol topical emulsion |
Estrasorb |
 |
| October 8, 2003 |
eplerenone |
Inspra |
 |
| October 2, 2003 |
ferric (III) hexacyanoferrate (II) |
Radiogardase |
 |
| September 12, 2003 |
daptomycin for injection |
Cubicin |
 |
| September 5, 2003 |
ethinyl estradiol and levonorgestrel |
Seasonale |
 |
| August 19, 2003 |
vardenafil |
Levitra |
 |
| August 13, 2003 |
Stair-climbing wheelchair |
INDEPENDENCE iBOT 3000 Mobility System |
 |
| August 12, 2003 |
rosuvastatin |
Crestor |
 |
| August 4, 2003 |
porfimer sodium |
Photofrin |
 |
| July 25, 2003 |
None |
ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) |
 |
| July 24, 2003 |
etanercept |
Enbrel |
 |
| July 18, 2003 |
None |
PLAC |
 |
| July 9, 2003 |
None |
West Nile Virus IgM Capture ELISA |
 |
| July 7, 2003 |
None |
Medtronic MiniMed Paradigm insulin pump with a Becton Dickinson glucose monitor |
 |
| June 25, 2003 |
pravastatin sodium/buffered aspirin |
Pravigard PAC |
 |
| June 20, 2003 |
atropine autoinjector |
Atropen |
 |
| June 20, 2003 |
omalizumab |
Xolair |
 |
| June 20, 2003 |
atazanavir sulfate |
Reyataz |
 |
| June 17, 2003 |
Influenza virus vaccine live, intranasal |
FluMist |
 |
| May 20, 2003 |
imatinib mesylate |
Gleevec |
 |
| May 16, 2003 |
none |
Platelia Aspergillus EIA |
 |
| May 15, 2003 |
none |
Biotronik's implantable cardioverter defibrillator |
 |
| May 13, 2003 |
bortezomib |
Velcade |
 |
| May 5, 2003 |
gefitinib |
Iressa |
 |
| May 1, 2003 |
none |
NIOX Nitric Oxide Test System |
 |
NOTE: Click on the to read the details of the approval.
| Date |
: |
May 11, 2006 |
| Generic Name |
: |
varenicline tartrate |
| Trade Name |
: |
Chantix ® tablets |
| Manufacturer |
: |
Pfizer, Inc. |
| Type of Drug/Product |
: |
smoking cessation medication |
| FDA Release |
: |
The FDA announced approval of Chantix, a smoking cessation tablet. It
acts at sites in the brain affected by nicotine and may help those who
wish to give up smoking in two ways. It provides some nicotine effects
to ease the withdrawal symptoms and also blocks the effects of nicotine
from cigarettes if the user resumes smoking. |
| Date |
: |
May 3, 2006 |
| Generic Name |
: |
decitabine |
| Trade Name |
: |
Dacogen injection |
| Manufacturer |
: |
Pharmachemie B.V. Haarlem, The Netherlands for MGI PHARMA, INC., Bloomington, MN. |
| Type of Drug/Product |
: |
treatment for myelodysplastic syndromes |
| FDA Release |
: |
The
FDA approved Dacogen (decitabine) injection for the treatment of
myelodysplastic syndromes. Dacogen is a new molecular entity that
received orphan drug status. Orphan products are developed to treat
rare diseases or conditions that affect fewer than 200,000 people in
the U.S. The Orphan Drug Act provides a seven-year period of exclusive
marketing to the first sponsor who obtains marketing approval for a
designated orphan drug. |
| Date |
: |
March 16, 2006 |
| Generic Name |
: |
tool for cancer detection |
| Trade Name |
: |
LUMA Cervical Imaging System |
| Manufacturer |
: |
MediSpectra, Inc. |
| Type of Drug/Product |
: |
tool to help catch cervical cancer |
| FDA Release |
: |
The
FDA approved a new imaging system that can help detect a cervical
cancer precursor, an indication that cancer is developing, by
identifying sites on the cervix that may have pre-cancerous cells. |
| Date |
: |
March 1, 2006 |
| Generic Name |
: |
cetuximab |
| Trade Name |
: |
Erbitux |
| Manufacturer |
: |
ImClone Systems Inc. |
| Type of Drug/Product |
: |
treatment of squamous cell cancer of the head and neck |
| FDA Release |
: |
The FDA announced the approval of Erbitux for use in combination with
radiation therapy to treat patients with squamous cell cancer of the
head and neck that cannot be treated with surgery. Erbitux was also
approved for use alone to treat patients whose head and neck cancer has
spread despite using standard chemotherapy. |
| Date |
: |
February 28, 2006 |
| Generic Name |
: |
selegiline |
| Trade Name |
: |
Emsam |
| Manufacturer |
: |
Bristol-Myers Squibb |
| Type of Drug/Product |
: |
treatment for depression |
| FDA Release |
: |
Emsam,
the first skin patch for treating major depression, was approved by the
FDA. The once-a-day patch works by delivering selegiline, a monoamine
oxidase inhibitor (MAOI), through the skin and into the bloodstream. At
its lowest strength, Emsam can be used without the dietary restrictions
that are needed for MAOIs taken by mouth. |
| Date |
: |
February 22, 2006 |
| Generic Name |
: |
generic version of the brand name drug Flonase |
| Trade Name |
: |
Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase |
| Manufacturer |
: |
Roxane Laboratories of Columbus, OH |
| Type of Drug/Product |
: |
treats the nasal symptoms of seasonal and chronic (long-lasting) allergic and nonallergic rhinitis |
| FDA Release |
: |
The
FDA approved Fluticasone Propionate Nasal Spray, the first generic
version of the brand name drug Flonase, giving American consumers an
additional, lower cost alternative when choosing prescription drug
products. |
| Date |
: |
February 21, 2006 |
| Generic Name |
: |
anidulafungin |
| Trade Name |
: |
Eraxis |
| Manufacturer |
: |
Pfizer Inc. of New York, NY. |
| Type of Drug/Product |
: |
treatment of infections caused by a certain fungus |
| FDA Release |
: |
The
FDA approved Eraxis to treat certain infections caused by Candida, a
yeast-like fungus that can cause serious infections in hospitalized
patients or patients with compromised immune systems. |
|